Physician

Simardeep Mangat, MD

According to 2025 Medicare claims, Simardeep Mangat, MD (NPI: 1063518074) practices nephrology in the Syracuse, NY market, with the plurality of this provider's patient population coming from Onondaga, NY. This provider's primary affiliated billing organization is NEPHROLOGY ASSOCIATES OF SYRACUSE, P.C. (NPI: 1831276823; TIN: 160986361) and primary practice location at 13212-4311. Mangat is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Mangat's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,042 traditional Medicare patients, billed 19,746 HCPCS/CPT codes, and received $346,048 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,227 prescription claims across 571 beneficiaries totaling $303,112 in drug costs, led by Jardiance (Empagliflozin). DME data shows 36 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $2,208 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,273	30,179	$352,559
2016	1,300	36,188	$380,463
2017	1,144	25,429	$345,710
2018	1,156	27,892	$352,161
2019	1,146	29,390	$358,181
2020	1,125	28,498	$357,262
2021	1,084	26,846	$407,304
2022	1,085	32,580	$428,873
2023	1,041	25,786	$367,665
2024	1,042	19,746	$346,048

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	370	2,315	$300,431
2016	377	2,576	$367,339
2017	427	2,623	$382,531
2018	486	2,798	$244,299
2019	535	2,973	$228,021
2020	547	3,190	$241,052
2021	586	3,353	$269,168
2022	565	3,039	$243,289
2023	539	2,905	$290,025
2024	571	3,227	$303,112

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	94	$8,453
2016	N/R	125	$12,710
2017	N/R	191	$14,539
2018	N/R	115	$4,902
2019	N/R	88	$7,746
2020	N/R	71	$2,510
2021	N/R	72	$1,349
2022	N/R	40	$420
2023	N/R	13	$150
2024	N/R	36	$1,225

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	830	1,597	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	821	1,588	$12
36415	Insertion of needle into vein for collection of blood sample	774	1,518	$9
80069	Kidney function blood test panel	746	1,443	$9
82570	Creatinine level to test for kidney function or muscle injury	754	1,432	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	68	2,695	$52,118
Farxiga	Dapagliflozin Propanediol	38	2,274	$39,942
Tradjenta	Linagliptin	35	1,793	$30,175
Velphoro	Sucroferric Oxyhydroxide	15	450	$29,654
Cinacalcet Hcl	Cinacalcet Hcl	27	2,075	$27,889

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7520	Sirolimus, oral, 1 mg	N	N/R	13	$949
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	23	$276

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Simardeep Mangat, MD?

Tedicare shows public-source Medicare data for Simardeep Mangat, MD (NPI 1063518074), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Simardeep Mangat, MD have ACO affiliation data?

Simardeep Mangat, MD is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Simardeep Mangat, MD?

Simardeep Mangat, MD is linked to NEPHROLOGY ASSOCIATES OF SYRACUSE, P.C. (billing NPI 1831276823) in the available physician profile data.

Does Simardeep Mangat, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.